Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity

James C. Burnett, James J. Schmidt, Robert G. Stafford, Rekha G. Panchal, Tam L. Nguyen, Ann R. Hermone, Jonathan L. Vennerstrom, Connor F. McGrath, Douglas J. Lane, Edward A. Sausville, Daniel W. Zaharevitz, Rick Gussio, Sina Bavari

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Botulinum neurotoxins (BoNTs) are among the most lethal biological substances to have been weaponized and are listed as biodefense category A agents. Currently, no small molecule (non-peptidic) therapeutics exist to counter this threat; hence, identifying and developing compounds that inhibit BoNTs is a high priority. In the present study, a high-throughput assay was used to identify small molecules that inhibit the metalloprotease activity of BoNT serotype A light chain (BoNT/A LC). All inhibitors were further verified using a HPLC-based assay. Conformational analyses of these compounds, in conjunction with molecular docking studies, were used to predict structural features that contribute to inhibitor binding and potency. Based on these results, a common pharmacophore for BoNT/A LC inhibitors is proposed. This is the first study to report small molecules (non-peptidics) that inhibit BoNT/A LC metalloprotease activity in the low μM range.

Original languageEnglish (US)
Pages (from-to)84-93
Number of pages10
JournalBiochemical and Biophysical Research Communications
Volume310
Issue number1
DOIs
StatePublished - Oct 10 2003

Fingerprint

Type A Botulinum Toxins
Neurotoxins
Metalloproteases
Molecules
Assays
High Pressure Liquid Chromatography
Throughput
Light
Therapeutics

Keywords

  • Bioterrorism
  • Botulinum neurotoxin
  • Drug discovery
  • High-throughput screen
  • Inhibitors
  • Metalloprotease
  • Molecular modeling
  • Pharmacophore
  • Three-dimensional database search

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Burnett, J. C., Schmidt, J. J., Stafford, R. G., Panchal, R. G., Nguyen, T. L., Hermone, A. R., ... Bavari, S. (2003). Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochemical and Biophysical Research Communications, 310(1), 84-93. https://doi.org/10.1016/j.bbrc.2003.08.112

Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. / Burnett, James C.; Schmidt, James J.; Stafford, Robert G.; Panchal, Rekha G.; Nguyen, Tam L.; Hermone, Ann R.; Vennerstrom, Jonathan L.; McGrath, Connor F.; Lane, Douglas J.; Sausville, Edward A.; Zaharevitz, Daniel W.; Gussio, Rick; Bavari, Sina.

In: Biochemical and Biophysical Research Communications, Vol. 310, No. 1, 10.10.2003, p. 84-93.

Research output: Contribution to journalArticle

Burnett, JC, Schmidt, JJ, Stafford, RG, Panchal, RG, Nguyen, TL, Hermone, AR, Vennerstrom, JL, McGrath, CF, Lane, DJ, Sausville, EA, Zaharevitz, DW, Gussio, R & Bavari, S 2003, 'Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity', Biochemical and Biophysical Research Communications, vol. 310, no. 1, pp. 84-93. https://doi.org/10.1016/j.bbrc.2003.08.112
Burnett, James C. ; Schmidt, James J. ; Stafford, Robert G. ; Panchal, Rekha G. ; Nguyen, Tam L. ; Hermone, Ann R. ; Vennerstrom, Jonathan L. ; McGrath, Connor F. ; Lane, Douglas J. ; Sausville, Edward A. ; Zaharevitz, Daniel W. ; Gussio, Rick ; Bavari, Sina. / Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. In: Biochemical and Biophysical Research Communications. 2003 ; Vol. 310, No. 1. pp. 84-93.
@article{8b513532b40b4ae9bc0bb3c42b71c2c6,
title = "Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity",
abstract = "Botulinum neurotoxins (BoNTs) are among the most lethal biological substances to have been weaponized and are listed as biodefense category A agents. Currently, no small molecule (non-peptidic) therapeutics exist to counter this threat; hence, identifying and developing compounds that inhibit BoNTs is a high priority. In the present study, a high-throughput assay was used to identify small molecules that inhibit the metalloprotease activity of BoNT serotype A light chain (BoNT/A LC). All inhibitors were further verified using a HPLC-based assay. Conformational analyses of these compounds, in conjunction with molecular docking studies, were used to predict structural features that contribute to inhibitor binding and potency. Based on these results, a common pharmacophore for BoNT/A LC inhibitors is proposed. This is the first study to report small molecules (non-peptidics) that inhibit BoNT/A LC metalloprotease activity in the low μM range.",
keywords = "Bioterrorism, Botulinum neurotoxin, Drug discovery, High-throughput screen, Inhibitors, Metalloprotease, Molecular modeling, Pharmacophore, Three-dimensional database search",
author = "Burnett, {James C.} and Schmidt, {James J.} and Stafford, {Robert G.} and Panchal, {Rekha G.} and Nguyen, {Tam L.} and Hermone, {Ann R.} and Vennerstrom, {Jonathan L.} and McGrath, {Connor F.} and Lane, {Douglas J.} and Sausville, {Edward A.} and Zaharevitz, {Daniel W.} and Rick Gussio and Sina Bavari",
year = "2003",
month = "10",
day = "10",
doi = "10.1016/j.bbrc.2003.08.112",
language = "English (US)",
volume = "310",
pages = "84--93",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity

AU - Burnett, James C.

AU - Schmidt, James J.

AU - Stafford, Robert G.

AU - Panchal, Rekha G.

AU - Nguyen, Tam L.

AU - Hermone, Ann R.

AU - Vennerstrom, Jonathan L.

AU - McGrath, Connor F.

AU - Lane, Douglas J.

AU - Sausville, Edward A.

AU - Zaharevitz, Daniel W.

AU - Gussio, Rick

AU - Bavari, Sina

PY - 2003/10/10

Y1 - 2003/10/10

N2 - Botulinum neurotoxins (BoNTs) are among the most lethal biological substances to have been weaponized and are listed as biodefense category A agents. Currently, no small molecule (non-peptidic) therapeutics exist to counter this threat; hence, identifying and developing compounds that inhibit BoNTs is a high priority. In the present study, a high-throughput assay was used to identify small molecules that inhibit the metalloprotease activity of BoNT serotype A light chain (BoNT/A LC). All inhibitors were further verified using a HPLC-based assay. Conformational analyses of these compounds, in conjunction with molecular docking studies, were used to predict structural features that contribute to inhibitor binding and potency. Based on these results, a common pharmacophore for BoNT/A LC inhibitors is proposed. This is the first study to report small molecules (non-peptidics) that inhibit BoNT/A LC metalloprotease activity in the low μM range.

AB - Botulinum neurotoxins (BoNTs) are among the most lethal biological substances to have been weaponized and are listed as biodefense category A agents. Currently, no small molecule (non-peptidic) therapeutics exist to counter this threat; hence, identifying and developing compounds that inhibit BoNTs is a high priority. In the present study, a high-throughput assay was used to identify small molecules that inhibit the metalloprotease activity of BoNT serotype A light chain (BoNT/A LC). All inhibitors were further verified using a HPLC-based assay. Conformational analyses of these compounds, in conjunction with molecular docking studies, were used to predict structural features that contribute to inhibitor binding and potency. Based on these results, a common pharmacophore for BoNT/A LC inhibitors is proposed. This is the first study to report small molecules (non-peptidics) that inhibit BoNT/A LC metalloprotease activity in the low μM range.

KW - Bioterrorism

KW - Botulinum neurotoxin

KW - Drug discovery

KW - High-throughput screen

KW - Inhibitors

KW - Metalloprotease

KW - Molecular modeling

KW - Pharmacophore

KW - Three-dimensional database search

UR - http://www.scopus.com/inward/record.url?scp=0141625732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141625732&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2003.08.112

DO - 10.1016/j.bbrc.2003.08.112

M3 - Article

C2 - 14511652

AN - SCOPUS:0141625732

VL - 310

SP - 84

EP - 93

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -